Disease | N. SNPs d | DSI v | DPI v | Chr | Position | Consequence | Alleles | Class | AFEXOME | AFGENOME | Score vda | EI vda | N. PMIDs | First Ref. | Last Ref. | ||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Psoriasis
|
705 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.700 | 1.000 | 1 | 2015 | 2015 | ||||
Hyperparathyroidism, Primary
|
39 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.080 | 0.875 | 8 | 2001 | 2016 | ||||
Kidney Calculi
|
71 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.060 | 1.000 | 6 | 2006 | 2019 | ||||
Nephrolithiasis
|
99 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.060 | 1.000 | 6 | 2006 | 2019 | ||||
Chronic kidney disease stage 5
|
194 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.020 | 1.000 | 2 | 2002 | 2009 | ||||
Kidney Failure, Chronic
|
425 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.020 | 1.000 | 2 | 2002 | 2009 | ||||
Urolithiasis
|
33 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.020 | 1.000 | 2 | 2015 | 2017 | ||||
Colon Carcinoma
|
275 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Hypercalcemia
|
9 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Hyperparathyroidism
|
14 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Hyperparathyroidism, Secondary
|
4 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Hypertriglyceridemia
|
169 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2014 | 2014 | ||||
Hypocalcemia
|
13 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||
Idiopathic hypercalciuria
|
1 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||
Kidney Failure
|
36 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2002 | 2002 | ||||
Malignant neoplasm of prostate
|
1082 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Malignant tumor of colon
|
688 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2017 | 2017 | ||||
Multiple Endocrine Neoplasia Type 1
|
156 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Pancreatitis
|
80 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1 | 2007 | 2007 | |||||
Pancreatitis, Chronic
|
56 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2008 | 2008 | ||||
Parathyroid Gland Adenocarcinoma
|
22 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2012 | 2012 | ||||
Prostate carcinoma
|
1168 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2010 | 2010 | ||||
Vitamin D Deficiency
|
37 | 0.672 | 0.360 | 3 | 122284922 | missense variant | A/G | snv | 0.15 | 9.0E-02 | 0.010 | 1.000 | 1 | 2015 | 2015 |